NEW YORK (GenomeWeb) – An international team led by investigators at the Dana-Farber Cancer Institute and the Children's Hospital of Philadelphia has detected a gene fusion that contributes to the development of a form of pediatric low-grade glioma called angiocentric glioma through three distinct mechanisms.